The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism.

Francesco AndreozziGregory Alexander RacitiCecilia NigroGaia Chiara ManninoTeresa ProcopioAlberto M DavalliFrancesco BeguinotGiorgio SestiClaudia MieleFranco Folli

Published in: Journal of translational medicine (2016)

In L6 myotubes, EXE and liraglutide increase glucose uptake in an insulin-independent manner by activating AMPK.

Keyphrases

blood glucose
skeletal muscle
type diabetes
protein kinase
signaling pathway
glycemic control
blood pressure
metabolic syndrome